Michaela M. Mocanu - Concepedia

Author

Michaela M. Mocanu

Also Known As

M M Mocanu, M Mocanu, M.M. Mocanu, Michaela M. Mocanu, Mocanu, M, Mora Mocanu

Publications

291

Citations

H-Index

Concepts

All Affiliations

Michaela M. Mocanu is an author at University College London specializing in cardiology, medicine, and cardiovascular disease.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	78
2	Public Health	1	1	26
3	Cell Biology	1	1	52
4	Diabetes	1	1	26
5	Emergency Medicine	1	1	26

Michaela M. Mocanu

Publications

263

Citations

H-Index

Page 1

	Year	Citations
Cardioprotective Effects of Transforming Growth Factor-β1 During Early Reoxygenation or Reperfusion Are Mediated by p42/p44 MAPK Gary F. Baxter, Michaela M. Mocanu, Bhawanjit K. Brar, Journal of Cardiovascular Pharmacology	2001	103
Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol‐3 kinase and ERK1/2 activation Naveen R. Mudalagiri, Michaela M. Mocanu, Carmelo Di Salvo, British Journal of Pharmacology	2007	55
Temporal Changes in Myocardial Salvage Kinases During Reperfusion Following Ischemia: Studies Involving the Cardioprotective Adipocytokine Apelin Christopher Smith, Michaela M. Mocanu, Jonathan P. Bowen, Cardiovascular Drugs and Therapy InflammationHeart FailureCardiovascular DiseaseTemporal ChangesMyocardial Salvage Kinases	2007	52
Mibefradil, a T-Type and L-Type Calcium Channel Blocker, Limits Infarct Size through a Glibenclamide-Sensitive Mechanism Michaela M. Mocanu, Shashi Gadgil, Derek M. Yellon, Cardiovascular Drugs and Therapy	1999	27
Attenuation of Myocardial Ischaemic Injury 24 h After Diacylglycerol TreatmentIn Vivo Gary F. Baxter, Michaela M. Mocanu, Derek M. Yellon Journal of Molecular and Cellular Cardiology ThrombosisCardiogenic ShockCardiovascular DiseaseAtherosclerosisDiacylglycerol Treatmentin Vivo	1997	26

Page 1